Novartis AG Financial Performance and Market Position AnalysisNovartis AG (NYSE:NVS), a leading global healthcare company, is renowned for its innovative pharmaceuticals. The company is a key player in the pharmaceutical industry, competing with giants like Pfizer and Merck. On October 28, 2025, Novartis reported an earnings per share (EPS) of $2.25, slightly below the expected$2.26. However, the company achieved a revenue of approximately $13.9 billion, surpassing the estimated$13.8 billion, as reported ...